These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28724184)

  • 1. Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case.
    Costabile L; Unfer V
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):73-76. PubMed ID: 28724184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of myo-inositol on glucose variability in women with gestational diabetes.
    Pintaudi B; Di Vieste G; Corrado F; Lucisano G; Giunta L; D'Anna R; Di Benedetto A
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6567-6572. PubMed ID: 30338829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
    Santamaria A; Di Benedetto A; Petrella E; Pintaudi B; Corrado F; D'Anna R; Neri I; Facchinetti F
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3234-7. PubMed ID: 26698911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.
    D'Anna R; Scilipoti A; Giordano D; Caruso C; Cannata ML; Interdonato ML; Corrado F; Di Benedetto A
    Diabetes Care; 2013 Apr; 36(4):854-7. PubMed ID: 23340885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial.
    Esmaeilzadeh S; Ghadimi R; Mashayekh-Amiri S; Delavar MA; Basirat Z
    Minerva Obstet Gynecol; 2023 Aug; 75(4):357-364. PubMed ID: 35686634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
    Guo X; Guo S; Miao Z; Li Z; Zhang H
    J Diabetes Complications; 2018 Mar; 32(3):342-348. PubMed ID: 29325728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-pharmacological management of gestational diabetes: The role of myo-inositol.
    Guardo FD; Currò JM; Valenti G; Rossetti P; Di Gregorio LM; Conway F; Chiofalo B; Garzon S; Bruni S; Rizzo G
    J Complement Integr Med; 2019 Sep; 17(2):. PubMed ID: 31527297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Vitagliano A; Saccone G; Cosmi E; Visentin S; Dessole F; Ambrosini G; Berghella V
    Arch Gynecol Obstet; 2019 Jan; 299(1):55-68. PubMed ID: 30564926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very tight vs. tight control: what should be the criteria for pharmacologic therapy dose adjustment in diabetes in pregnancy? Evidence from randomized controlled trials.
    Caissutti C; Saccone G; Ciardulli A; Berghella V
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):235-247. PubMed ID: 29125636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
    Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C
    J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-inositol supplementation for prevention of gestational diabetes mellitus in overweight and obese pregnant women: a systematic review and meta-analysis.
    Mashayekh-Amiri S; Mohammad-Alizadeh-Charandabi S; Abdolalipour S; Mirghafourvand M
    Diabetol Metab Syndr; 2022 Jul; 14(1):93. PubMed ID: 35794663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus.
    Kısa B; Sert UY; Celik HK; Candar T; Erol Koç EM; Taşcı Y; Çağlar GS
    Arch Physiol Biochem; 2022 Aug; 128(4):910-913. PubMed ID: 32191130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
    Vitale SG; Corrado F; Caruso S; Di Benedetto A; Giunta L; Cianci A; D'Anna R
    Int J Food Sci Nutr; 2021 Aug; 72(5):670-679. PubMed ID: 33238798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study group of India (DIPSI) criteria] as a diagnostic test for gestational diabetes mellitus.
    Tripathi R; Verma D; Gupta VK; Tyagi S; Kalaivani M; Ramji S; Mala YM
    Indian J Med Res; 2017 Feb; 145(2):209-214. PubMed ID: 28639597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus.
    Celentano C; Matarrelli B; Mattei PA; Pavone G; Vitacolonna E; Liberati M
    Curr Diab Rep; 2016 Mar; 16(3):30. PubMed ID: 26898405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet and Nutritional Interventions with the Special Role of Myo-Inositol in Gestational Diabetes Mellitus Management. An Evidence-Based Critical Appraisal.
    Reyes-Muñoz E; Guardo FD; Ciebiera M; Kahramanoglu I; Sathyapalan T; Lin LT; Shah M; Karaman E; Fan S; Zito G; Noventa M
    Curr Pharm Des; 2019; 25(22):2467-2473. PubMed ID: 31333107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis.
    Zheng X; Liu Z; Zhang Y; Lin Y; Song J; Zheng L; Lin S
    Medicine (Baltimore); 2015 Oct; 94(42):e1604. PubMed ID: 26496267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.
    Fraticelli F; Celentano C; Zecca IA; Di Vieste G; Pintaudi B; Liberati M; Franzago M; Di Nicola M; Vitacolonna E
    Acta Diabetol; 2018 Aug; 55(8):805-812. PubMed ID: 29774465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inositol and its derivatives on diabetes: a systematic review.
    Özturan A; Arslan S; Kocaadam B; Elibol E; İmamoğlu İ; Karadağ MG
    Crit Rev Food Sci Nutr; 2019; 59(7):1124-1136. PubMed ID: 29053004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.